血清甲状腺激素与儿童脓毒症早期诊断及病情的相关性研究
摘要
关键词
全文:
PDF参考
Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children[J]. Intensive Care Med, 2020, 46(Suppl 1): 10-67.
DOWNES K J, FITZGERALD J C,WEISS S L. Utility of procalcitonin as a biomarker for sepsis in children[J]. J Clin Microbiol,2020,58(7):01851.
朱德胜,曾方玲,罗兰.脓毒症危重患儿血清降钙素原水平变化及 临床意义[J]. 实用检验医师杂志,2017,9(4):241-243.
Eschborn S, Weitkamp JH. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. J Perinatol. 2019 Jul;39(7):893-903.
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377.
Dietz BW , Jones TK, Small DS, Gaieski DF , Mikkelsen ME. The Rela-tionship Between Index Hospitalizations, Sepsis, and Death or Transi-tion to Hospice Care During 30-Day Hospital Readmissions. Med Care 2017; 55: 362-370.
Arefian H, Heublein S, Scherag A, et al. Hospital-related cost of sep-sis: asystematic review. J Infect 2017; 74: 107-117.
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ ATS/SIS International Sepsis Definitions Conference[J].
陈灏珠,林果为.实用内科学:上册[M].北京:人民卫生出版 社,2009.
尹小燕,乔建瓯.甲状腺激素、降钙素原和C-反应蛋白对脓毒症 患者病情及预后评估的价值[J].中华实验和临床感染病杂志(电 子版),2016,10(2):162-165.
Stefanie M, Philipp S, Melanie W, et al.Low triiodothyronine syndrome:a prognostic marker for outcome in sepsis?[J].Endocr, 2011,39(2):167-174.
Thiery Antier N, Binquet C, Vinault S, et al. Is thrombocytopenia an early prognostic marker in septic shock[J]. Crit Care Med,2016,44(4):764-772.
DOI: https://doi.org/10.12346/pmr.v4i2.6093
Refbacks
- 当前没有refback。